info@biomedres.us   +1 (720) 414-3554   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Research ArticleOpen Access

Early Treatment of Acute Infective Tricuspid and Aortic Valve Active Endocarditis: The “Bio” Solution

Volume 9 - Issue 5

Saitto G*, Mossuto E, Garatti A, Daprati A, De Vincentiis C and Menicanti L

  • Author Information Open or Close
    • Cardiac Surgery Unit, IRCCS Policlinico San Donato Milanese, San Donato Milanese (MI) Italy
    • *Corresponding author: Guglielmo Saitto, Cardiac Surgery Unit, IRCCS Policlinico San Donato Milanese, San Donato Milanese (MI) Italy

Received:October 02, 2018;   Published: October 11, 2018

DOI: 10.26717/BJSTR.2018.09.001874

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Although infective is a relatively rare infectious disease it remains a potentially lethal disease with a high morbidity and mortality rate despite medical and surgical advances. Furthermore, the best treatment and timing are often debate. We present the case of a young man with drug addiction and hepatitis B and C, who clinically presented with acute fever, dyspnea, severe anemia and hemoptysis. Acute tricuspid and aortic valve endocarditis by S. Aureus was clinically and echocardiography diagnosed and an early surgical treatment by aortic and tricuspid valve replacement by BioAorticTM and BioMitralTM prosthesis was successfully chosen.

Keywords : Infective Endocarditis; Aortic Valve Replacement; Tricuspid Valve Replacement

Abstract | Introduction| Case Report| Comment| References|